Angiotensin II is a prothrombotic vasoconstrictor. This study proves t
hat many hypertensives are hypercoagulable and at risk for myocardial
infarction. The modified recalcification time (MRT) test, used to asse
ss hypercoagulability, incorporates the role of tissue factor in coagu
lation by activating the monocyte with endotoxin to release latent tis
sue factor. Aliquots of citrated blood obtained from hypertensives and
normotensive controls were placed in two groups of vials, one with sa
line (group S) and one with endotoxin (group E). All vials were incuba
ted at 37-degrees-C for 2 hours, citrate neutralized with calcium chlo
ride, and the MRT (in minutes) for group S (MRT S) and for group E (MR
T E) was determined. Mean MRT S values +/- standard deviation (SD) for
hypertensives (n = 25) and for controls (n = 27) were 6.4 +/- 1.2 and
6.8 +/- 1.2, respectively. The MRT E values were 4.3 +/- 1.2 and 5.7
+/- 0.9 for the hypertensives and controls, respectively. The MRT E, n
ot the MRT S, was significant. Hypertensives had MRT E values <4.5 min
utes, and by our established criteria, were hypercoagulable. We conclu
de that because hypercoagulability is a risk factor for thrombosis, hy
pertensives with short MRT E values may be at increased risk for myoca
rdial or other thrombotic events.